Clinical Trial Update: Effects of Repeated Psilocybin Dosing in OCD [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the effects of repeated psilocybin dosing in Obsessive-Compulsive Disorder; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Yale University | Conditions: Obsessive-Compulsive Disorder | Phase 1 | Status: ACTIVE_NOT_RECRUITING